baber/WOPTO huggingface dataset:
Patent JP-2001509965-A (JP)
Title: 軸方向空冷を組み合わせた変圧器
IPC: H01F27/08
Filed: 1998-02-02
Abstract: (57)【要約】
電力変圧器（１）は変圧器鉄心を備えており、該鉄心は高電圧ケーブル（１１１）で巻かれており、該ケーブルは、可撓性であり、そして内側半導電層（１１３）で囲われた電気的に導電性の心線と、内側半導電層（１１３）を囲む固体材料の絶縁層（１１４）と、及び該絶縁層（１１４）を囲む外側半導電層（１１５）を含んでおり、前記層（１１３、１１４、１１５）は、互いに接着しており、巻線（２）が、冷却ダクト（３）を形成するディスクを作るために、軸方向に各ケーブルターンを分離するように配置されるスペーサを備えている。
Patent JP-2001513120-A (JP)
Title: ペプチドを含むポリマー
IPC: A61K47/48
Filed: 1998-02-10
Abstract: (57)【要約】
本発明は、ペプチドを含むポリマー結合ペプチドを提供するものである。第１の実施態様においては、このポリマーは、（１）CH 2 =CR 4 -CO-X-R 1 および（２）CH 2 =CR 3 -CO-R 2 、ならびに任意に１以上のその他のモノマーの重合単位を含む。第２の実施態様においては、本発明は、CH 2 =CR 4 -CO-X-R 1 および任意に１以上のその他のモノマーから形成されたポリマーを提供する。ここで、Ｘは１〜30のＣ−Ｃ単結合と等価の長さを有するスペーサーであり、R 1 はペプチドであり、各R 1 は同一または異なるものであり、-COR 2 はエステルまたはアミドおよび本明細書で定義されたようなそれらの誘導体である。本発明は、さらに、前記ポリマーを製造する方法および該ポリマーを用いて免疫応答を誘導する方法に関する。
Patent JP-2000507243-A (JP)
Title: Ｌｈｒｈ拮抗剤合成のための方法と中間生成物
IPC: C07K5/083
Filed: 1997-02-06
Abstract: (57)【要約】
液相ペプチド化学法による、ＬＨＲＨのデカペプチドとアンデカペプチド誘導体を調製するための方法と、同法において有用な中間生成ペプチドとが提供される。
Patent JP-2001508117-A (JP)
Title: 燃料−水−エマルジョン
IPC: C10L1/12
Filed: 1998-01-09
Abstract: (57)【要約】
本発明は、実質的に６０〜８０重量％の燃料、０．  ５〜５重量％の、式（Ａ）
 ［式中、Ｒはそれぞれ炭素原子数８〜１８のアルキルーまたはアルケニル基またはＣ 9 〜Ｃ 14 −アルキルフェニル基でありそしてｘは８〜３０の整数を意味する。］で表される１種類以上の水溶性でガソリン不溶性の乳化剤、または
 ［式中、エチレンオキシド単位の割合が分子の４０〜８０重量％である。］または（Ｃ）
 ［式中、ｘは１０〜３０の数を意味する。］および１〜１０重量％の安定剤としての水溶性でガソリン不溶性のポリアルキレングリコール並びに全体として１００重量％とするのに必要な量の水と場合によっては別の添加物より成る燃料−水−エマルジョンに関する。本発明のエマルジョンは内燃機関の運転に使用できる。
Patent JP-H11504939-A (JP)
Title: 胃腸障害の治療及び予防用のビスマス含有組成物
IPC: A61K33/24
Filed: 1996-05-08
Abstract: (57)【要約】
本発明は、１以上の寄生原生動物に起因した又は仲介された胃腸障害を有するヒト又は下等動物の被験体の予防及び治療方法であって、ビスマスを前記被験体へ投与することを含む方法。
Patent JP-2000507740-A (JP)
Title: シールドされたモジュールを有するコネクタ組立体
IPC: H01R13/514
Filed: 1997-03-20
Abstract: (57)【要約】
電気コネクタ組立体（１０）は、絶縁ハウジング(１２)、及びそれに組付けられた複数の端子モジュール(３０)、及びその間の導電シールド（８０）を含む。各端子モジュール（３０）は、複数のコンタクト（３６）を有し、このコンタクトは、嵌合接触部(３８)、導体接続部(４２)、及びその間の中間部（４０）を含み、中間部のいくつか、あるいは全部は絶縁ウェブ（５６）に封止される。各モジュール（３０）は、そこに取付けられた導電シールド（８０）を有する。このコネクタ組立体（１０）は、各シールド（８０）が、それが取付けられるモジュール内の選択されたコンタクトの一つと電気的に接触する少なくとも第１弾性アーム（９８）を含み、またモジュールから外方に延び、コネクタ組立体（１０）の隣接する端子モジュール（３０）の他の選択されたコンタクトと電気的に接触する少なくとも第２弾性アーム（９９）を有することを特徴とする。
Patent JP-2000508301-A (JP)
IPC: A61K47/14
Filed: 1997-03-27
Abstract: PCT No. PCT/EP97/01569 Sec. 371 Date Oct. 6, 1998 Sec. 102(e) Date Oct. 6, 1998 PCT Filed Mar. 27, 1997 PCT Pub. No. WO97/37653 PCT Pub. Date Oct. 16, 1997Injection formulations of avermectins and milbemycins based on castor oil are disclosed.
Patent JP-H11507330-A (JP)
Title: オキサゾリジノン誘導体、その製造及び治療的使用
IPC: A61K31/427
Filed: 1996-05-28
Abstract: (57)【要約】
 開示された５−（ヒドロキシメチル）オキサゾリン−２−オン誘導体は、インダゾール、ベンズイソキサゾール又はベンズイソチアゾール環により３−置換され、一般式（Ｉ）［式中、Ｘは酸素原子、硫黄原子又はＮＲ基（Ｒは水素原子又は直鎖若しくは分岐鎖のＣ 1 −Ｃ 4 アルキル鎖である）を表し、Ｒ 1 は、水素原子又はメチル基を表し、Ｒ 2 は、（ｉ）Ｒ 3 Ｏ基（Ｒ 3 は、水素原子又は場合によりハロゲン原子若しくはニトロ若しくはメチレンジオキシ基で置換されているベンジル基を表すか又はメトキシエチル、ブチル、４,４,４−トリフルオロブチル、４,４,４−トリフルオロ−３−ヒドロキシブチル又は４,４,４−トリフルオロブタ−２−エニル基を表す）、又は（ｉｉ）−ＣＨ＝ＣＨ−Ｒ 4 又は−ＣＨ 2 −ＣＨ 2 −Ｒ 4 （Ｒ 4 は、水素原子又はフェニル、３,３,３−トリフルオロプロピル又は３,３,３−トリフルオロ−２−ヒドロキシプロピル基を表す）のいずれかを表す］で示される。さらにその製造方法及び治療上の適用も開示される。
Patent JP-2001512640-A (JP)
Title: 基地局アンテナ構成
IPC: H01Q5/00
Filed: 1998-02-06
Abstract: (57)【要約】
本発明は第１の周波数帯域で放射する複数の第１の放射要素（１１）と第２の周波数帯域で放射する複数の第２の放射要素（１２、１３、１４、１５）を含むアンテナ構成（１０）に関する。前記第１、第２の放射要素は異なる平面に配置される。前記第２の放射要素（１２、１３、１４、１５）は前記第１の放射要素（１１）に関して、各第２の放射要素が対応する第１の放射要素に一部重なるように配置される。各放射要素は少なくとも１つの共振次元（Ａ 10 ;ａ 10 ）をもち、前記第１の放射要素の共振次元（Ａ 10 ）は前記第２の放射要素の共振次元（ａ 10 ）の約２倍であり、前記第２の放射要素は前記第１の放射要素の約２倍の周波数または周波数帯域で放射する。
Patent JP-2000512117-A (JP)
Title: スレーブ交換機へデータ送信する方法
IPC: H04Q5/00
Filed: 1998-03-23
Abstract: (57)【要約】
本発明は、テレコミュニケーションシステムにおいて多数のスレーブ交換機へデータ送信する方法であって、スレーブ交換機(ＤＸＴ1-ＤＸＴ3)へデータを送信しそしてスレーブ交換機からデータ受信の確認を期待するような方法に係る。従来の方法より効率的で且つ信頼性の高い方法送信方法を得るために、確認が受け取られたスレーブ交換機(ＤＸＴ2)は、スレーブ交換機の１つ(ＤＸＴ3)がデータ受信を確認しない場合に、その確認が受信されないスレーブ交換機(ＤＸＴ3)へ上記データを送信するよう指令される。
Patent JP-2001523249-A (JP)
IPC: A61K38/00
Filed: 1998-04-23
Abstract: This invention provides combinations of a tolerance-inducing antigen such as insulin and a mucosal binding component that preferably binds ganglioside GM1. The components are present in a non-covalent arrangement. When administered to a mucosal surface, the combinations are effective in inducing specific immunological tolerance at a 10-fold lower dose than antigen alone. Tolerance is sustained for a number of weeks without the necessity of booster administrations. The compositions and procedures of this invention are of benefit for the prevention or amelioration of conditions attributable to an unwanted immunological response.
Patent MX-158364-A (MX)
Inventor: PHILLIPS JAMES DAVIS
IPC: F27B21/00
Filed: 1982-07-14
Abstract: A furnace for manufacturing silicon carbide comprises a broken ring (8) of raw materials in which is embedded a graphite electrical heating element (12). The ring (8) is free-standing and defines a central working space (32) in which is located a support (36). The furnace is enclosed by an annular wall (44) spaced from the ring (8) to define an annular working space. A track (38) is mounted on top of the wall (44) and a rotatable materials handling device (6) is mounted on the central support (36) and the track (38). Materials are discharged from an outlet (48) to form the ring (8) as the device (6) rotates. A geodesic dome roof prevents escape of pollutants to atmosphere.
Patent NZ-192775-A (NZ)
Title: Preparation of 1-phenyl-3,4-dihydro-5h-2-benzazepin-5-ones and precursors therein
Inventor: TRYBULSKI E
IPC: C07C49/813
Filed: 1980-01-31
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LU, NL, SE Compounds of the general formula  see diagramm : EP0052599,P6,F2  wherein X and Y each signify hydrogen, halogen with an atomic number of at most 35 or trifluoromethyl and Z signifies hydroxy, methanesulphonyloxy, toluenesulphonyloxy, bromine or chlorine. 1. Claims for the Contracting State : AT A process for the manufacture of propargyl derivatives of the general formula  see diagramm : EP0052599,P6,F1  wherein X and Y each signify hydrogen, halogen with an atomic number of at most 35 or trifluoromethyl and Z signifies hydroxy, methanesulphonyloxy, toluenesulphonyloxy, bromine or chlorine, characterized by reacting a compound of the general formula  see diagramm : EP0052599,P6,F3  wherein X and Y have the above significance, with propargyl alcohol in the presence of a palladium (II) salt, an organophosphine, a tertiary or secondary amine and of copper (I) iodide and, if desired, converting the resulting compound of formula I in which Z signifies hydroxy into a compound of formula I in which Z signifies methanesulphonyloxy, toluenesulphonyloxy, bromine or chlorine.
Patent NZ-210148-A (NZ)
Title: A process for the preparation of urea
Inventor: JONCHERS K
IPC: C07C67/00
Filed: 1984-11-08
Abstract: Process for preparing urea in which,
 in a synthesis zone, at a pressure of 125-350 bar and at the temperature belonging thereto, a urea synthesis solution containing carbamate and free ammonia is formed from carbon dioxide and an excess of ammonia,
 in a first decomposition step, at synthesis pressure or lower, a part of the carbamate is decomposed by supply of heat and the gas phase obtained in this process is condensed in a first condensition zone,
 in a second decomposition step, at a pressure of 4-40 bar, a further part of the carbamate still present is decomposed by supply of heat and the gas phase formed is separated off,
 in a further step, the remaining carbamate is removed in the form of a gas mixture containing ammonia and carbon dioxide, and this gas mixture is processed to form a solution of ammonia and carbon dioxide in water,
 and the remaining urea-containing solution is processed to form a concentrated urea solution. 
<??>The urea solution to be concentrated is introduced into the tubes of a shell and tube heat exchanger, the gas mixture from the second decomposition step is led into the shell side of heat exchanger at the end opposite the place where the urea solution to be concentrated is fed, the solution of ammonia and carbon dioxide in water is fed to the said shell side at a place located between the inlet for the gas mixture and the inlet for the urea solution to be concentrated, and the condensate is discharged from the shell side at the end where the urea solution is led into the tubes.
Patent NZ-216830-A (NZ)
Title: Carboxylic acid derivatives and pharmaceutical compositions
Inventor: WOLFF HANS PETER
IPC: C07C323/56
Filed: 1986-07-14
Abstract: PCT No. PCT/EP86/00406 Sec. 371 Date Mar. 12, 1987 Sec. 102(e) Date Mar. 12, 1987 PCT Filed Jul. 10, 1986 PCT Pub. No. WO87/00521 PCT Pub. Date Jan. 29, 1987.This invention relates to carboxylic acid derivatives and their use thereof. The compounds are useful in treatment of various diseases such as diabetes, prediabetic conditions, adipositas ailments or atherosclerosis.
Patent NZ-219165-A (NZ)
Title: N-heterocyclyl-4-piperidinamine derivatives and pharmaceutical compositions
Inventor: JANSSENS FRANS EDUARD
IPC: C07D471/04
Filed: 1987-02-04
Abstract: Pharmaceutical compsn. comprises as active ingredient a therapeuticall effective ant. of an N-(4-piperidinyl)-3H-imidazo (4,5-b) pyridine-2-amine or N-(4-piperidinyl)-1H-benzimidazole-2-amine cpd. of formula (I) or its pharmaceutically acceptable acid addn. salt or steroisomer: where L=H, 1-6C alkoxy-carbonyl or benzyloxyearbonyl, A= gp. of formula (a) -CH=CH-CH=CH-, (b) -N=CH-CH=CH-, (c) -CH2N-CH=CH-, (d) -CH0CH-N=CH- or (e) -CH=CH-CH=N-, where 1 or 2 H atoms of (a) - (e) may be replaced by halogen, 1-6C alkyl, 1-6C alkoxy, CF3 and/or OH gp(s).; R= H or 1-6C alkyl; R1=H, 1-10C alky, 3-6C cycloalkyl, Ar1 or 1-6C alkyl substd. by 1 or 2 Ar1; R2= H, 1-6C alkyl, 3-6C cycloalkyl, 1-6C alkyl -(O-, 1-6C alkoxy-CO- or Ar2 - 1-6C alkyl; Ar1 = phenyl (opt. substd. by 1-3 of halogen, OH, N02, CN CF3, 1-6C alyl, 1-6C alkoxy, 1-6C alkylthio, SH, NH2, mono-or di-(1-6C alkyl)-amino, carboxyl, 1-6C alkoxy -carbonyl and/or 1-6C alkyl -co-), thienyl, halothienyl, furanyl, 1-6C alkyl-furanyl, pyridinyl, pyraxinyl, thiazolyl or imidazolyl opt. substd. by 1-6C alkyl, and Ar2 = phenyl opt. substd. as in Ar1. Cpds. of formula (I) and salts and stereoisomers are new where R1=R1a= 1-6C alkyl substd. with 1-6C alkyl-substd. furanyl other than 5-methyl-2-furanyl.
Patent NZ-228016-A (NZ)
Title: Substituted piperazine derivatives and pharmaceutical derivatives thereof
Inventor: VAN WAUWE JEAN PIERRE FRANS
IPC: C07D257/04
Filed: 1989-02-16
Abstract: 5-Lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols having the formula <CHEM> wherein R<1> and R<2> each independently are hydrogen, C1-6alkyl or halo; R<3> and R<4> each independently are hydrogen, halo, amino, nitro or trifluoromethyl; Y is a heterocyclic radical of formula <CHEM> for use as a medicine. Compositions containing these compounds as active ingredient. Novel 4-(4-phenyhl-1-piperazinyl)phenols and methods for preparing these and the aforementioned compositions.
Patent NZ-233176-A (NZ)
Title: Vehicle wheel support for dynamic testing with upper platform movable in any horizontal direction
Inventor: GICEWICZ GERALD PAUL
IPC: G01M17/06
Filed: 1990-04-03
Abstract: The disclosure relates to a diagnostic testing device for diagnosing and testing chassis, mechanical, tire and tire tread problems in vehicles which simulates normal operating angles and normal vehicle weight conditions with the wheels of the vehicle being cycled and steered at a full range of vehicle speeds. The diagnostic testing device (10) includes a support (11) having a horizontal upper surface (12), a platform (13) movably coupled to the upper surface of the support so as to allow the platform to glide horizontally in any direction, and a pair of support rollers (20, 21) rotatably connected to the platform so as to provide rolling surfaces to contact the tire tread and which allow a tire to cycle and be steered when placed upon said rollers.
Patent NZ-234875-A (NZ)
Title: Using fused thermosetting plastics material to bond layer to component; temperature of layer reduced before bonding to retard curing of plastics material
Inventor: LEACH ROGER JOHN
IPC: C08L75/00
Filed: 1990-08-13
Abstract: PCT No. PCT/GB90/01286 Sec. 371 Date Feb. 14, 1992 Sec. 102(e) Date Feb. 14, 1992 PCT Filed Aug. 14, 1990 PCT Pub. No. WO91/02648 PCT Pub. Date Mar. 7, 1991.In manufacture of a glass architectural panel (FIG. 1) an aluminium foil is bonded to a glass sheet via a layer of thermosetting polyester powder-coating material. The powder is deposited on the foil as the foil unrolls and is melted to provide a fused layer which is then cooled to solidify the layer and arrest progress of curing. The solidified layer is sprayed with a silane adhesion promoter, before being heated momentarily to enable the foil with its adhering and solidified, but uncured, layer, to be rolled up for storage. The rolled foil is transferred nearer to a float-glass production line, where, after being heated to allow it to be unrolled, it is fed onto a hot glass sheet emerging from the line. The fused layer melts as it is brought down with the backing foil to contact the glass sheet and fulfil the cure of the powder material so as to establish the bond. Instead of a single foil, several may be provided overlapping one another (FIG. 3). Decorative effects can be obtained using different pigmentations of powder and partial metallization of the glass (FIG. 4). The technique of interrupting the cure is applicable to provision of a glass window (FIG. 5) and a glass laminate (FIG. 6).
Patent NZ-236330-A (NZ)
Title: Proteinaceous compound activatable by blood clotting enzyme to have fibrinolytic activity or inhibit clot formation, synthesis, genetic engineering, dna, vectors, host cells and medicaments
Inventor: EDWARDS RICHARD MARK
IPC: C07K7/64
Filed: 1990-12-04
Abstract: PCT No. PCT/GB90/01912 Sec. 371 Date Jun. 4, 1992 Sec. 102(e) Date Jun. 4, 1992 PCT Filed Dec. 7, 1990 PCT Pub. No. WO91/09118 PCT Pub. Date Jun. 27, 1991Proteinaceous compounds are activatable by enzymes of the clotting cascade to have fibrinolytic or clot formation inhibition activity. For example, a plasminogen analogue is activatable to plasmin by thrombin or Factor Xa. Fibrinolytic or clot formation inhibition activity is therefore directed to the site of clot formation.
Patent NZ-236562-A (NZ)
Title: Gaming machine with electronic funds transfer capability.
Inventor: LUCERO JAMES LEWIS
IPC: G06Q20/36
Filed: 1990-12-19
Abstract: The apparatus for enabling a gaming machine in an establishment to provide credit to a player operating the machine without the player leaving the machine. The gaming machine has a card reader associated with it for transmitting player related financial data to a remote location for approval. A first code identifies the particular gaming machine and a second code identifies the establishment in which the gaming machine is located. A visual display on the gaming machine indicates the amount of credit approved and usable by the player and enables the player to operate the gaming machine to use the credit.
Patent NZ-244470-A (NZ)
Title: Topical composition containing 4-biphenylacetic acid (felbinac)
Inventor: RAMSEY MICHAEL PETER
IPC: A61K31/192
Filed: 1992-09-24
Abstract: A pharmaceutical composition for topical application comprises 4-biphenylacetic acid (BPAA) or a pharmaceutically acceptable salt or ester thereof in a carrier which is adapted to form a quick-breaking foam, the composition being maintained under pressure. The composition can be applied topically for the rapid relief of painful inflammation.
Patent NZ-244761-A (NZ)
Title: Nozzle, actuator and hood for foamed product aerosol can
Inventor: TROTTA ROBERT A
IPC: B05B7/00
Filed: 1992-10-16
Abstract: A dispenser device for a foam producing gel includes an actuator and a hood, the actuator being mounted at the top of a gel container and having an inlet contacting the valve stem of the gel container and a nozzle having an outlet directed radially outwardly from the top of the container. The hood is open at the bottom and engages the outer surface of the actuator to cover the actuator when not in use. An opening is provided in the hood and a notch in the rim of the opening contacts a detent on the outer surface of the actuator to ensure that the hood opening is opposite the nozzle outlet of the actuator when the hood is in place. The hood opening when so positioned serves to inhibit excess foaming of gel remaining between the actuator inlet and nozzle outlet when the hood is in place after usage, and a notch is formed in the nozzle structure below the actuator outlet to provide a path of flow downwardly from the outlet as foamed product expands outwardly from the outlet.
Patent NZ-245243-A (NZ)
Title: Indole derivatives, intermediates and pharmaceutical compositions thereof
Inventor: MACOR JOHN E
IPC: A61K31/53
Filed: 1992-11-24
Abstract: PCT No. PCT/US92/08306 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Oct. 6, 1992 PCT Pub. No. WO93/11106 PCT Pub. Date Jun. 10, 1993Compounds of the formula    <IMAGE>  I  wherein Z is   <IMAGE>   or   <IMAGE>   R1 is   <IMAGE> re each independently C, N, O, or S; wherein the remaining variables are defined in the specification, and the pharmaceutically acceptable salts thereof. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent NZ-248375-A (NZ)
Title: Apparatus for sampling, adsorbing, and processing for analysis of polycyclic aromatic hydrocarbons, other organic compounds, hf, and sulphur oxides in air and gases produced by industry
Inventor: NAGY KALMAN
IPC: G01N7/02
Filed: 1993-08-11
Abstract: The invention concerns equipment for sampling and processing for analysis of PAH and other organic compounds, as well as hydrogen fluoride and sulphur oxides in air and in gas in production equipment. The equipment comprises a layered adsorption device 1 in which the adsorbents are dry. During sampling the adsorption device 1 is connected at its upper end to a probe 8 which is brought into contact with the object to be sampled, and connected at its lower end to a gel box 10, a pump 9 and a gas clock 12 in series. After the sampling, the adsorption device 1 may be connected directly to the extraction apparatus 11 for the processing of the sample.
Patent NZ-250505-A (NZ)
Title: Biphenylmethyl derivatives, preparation and use in pharmaceutical compositions thereof
Inventor: YANAGISAWA HIROAKI
IPC: C07D233/88
Filed: 1993-12-17
Abstract: Compounds of formula (I) : <CHEM>  [wherein: A represents a group (IIa), (IIb) or (IIc) : <CHEM>   <CHEM> R<1> is alkyl, alkenyl, cycloalkyl or a group of formula R<4>-Y-R<5>-, where: R<4> is hydrogen, alkyl, or cycloalkyl, R<5> is a single bond or alkylene, and Y is oxygen, sulphur or imino group; R<2> is hydrogen, halogen, Optionally substituted alkyl, optionally substituted alkenyl, optionally substituted cycloalkyl, hydroxy, amino, alkylamino, dialkylamino, formyl, alkylcarbonyl, alkoxy, alkylthio, cyano or nitro; R<3> is hydrogen, alkyl, carboxy, protected carboxy, carbamoyl or tetrazol-5-yl; X is of formula -CH=, -N= or -C(COOR<6>)=, where R<6> is hydrogen or a carboxy-protecting group; Z is a single bond, alkylene or vinylene; and B is carboxy, protected carboxy or tetrazol-5-yl]; and pharmaceutically acceptable salts and esters thereof have the ability to inhibit the action of angiotensin II and thus can be used for the treatment and prophylaxis of hypertension and cardiac iseases.
Patent NZ-260084-A (NZ)
Title: Method for determination of hemoglobin-bound adducts in blood
Inventor: KIN-FAI YIP
IPC: G01N33/72
Filed: 1994-03-14
Abstract: Disclosed is an improvement to the method of determining the concentration of a hemoglobin adduct in a blood sample by the steps of assaying the blood sample for the total amount of hemoglobin, assaying the blood sample for the hemoglobin adduct, and dividing the hemoglobin adduct concentration by the total hemoglobin concentration. The improvement involves normalizing the measurement of the hemoglobin adduct to the total amount of hemoglobin in the blood sample.
Patent NZ-291852-A (NZ)
Title: Uhf antenna has helical conductive tracks plated onto ceramic cylinder
Inventor: LEISTEN OLIVER PAUL
IPC: H01Q1/36
Filed: 1995-08-21
Abstract: An antenna for use at UHF and upwards has a cylindrical ceramic core (12) with a relative dielectric constant of at least 5. A three-dimensional radiating element structure, consisting of helical antenna elements (10A - 10D) on the cylindrical surface of the core (12) and connecting radial elements (10AR - 10AD) on a distal end face (12D) of the core, is formed by conductor tracks plated directly on the core surfaces. At the distal end face the elements are connected to an axially located feed structure in a plated axial passage (14) of the core (12). The antenna elements are connected together by a plated sleeve (20) covering a proximal part of the core (12) which, in conjunction with the feeder structure, forms an integral balun for matching to an unbalanced feeder.  Since the ceramic core fills the major part of the interior volume defined by the radiating element structure, the antenna is very much smaller than an air-cored antenna. It is also mechanically robust and electrically stable.
Patent NZ-301611-A (NZ)
Title: a peptide having vascular endothelial growth factor like properties, nucleic acid molecule encoding it and its use
Inventor: HAYWARD NICHOLAS KIM
IPC: C12N5/0793
Filed: 1996-02-22
Abstract: An isolated naturally occurring or recombinant human derived polypeptide comprising an amino acid sequence having at least 70% similarity to the amino sequence SEQ. ID NO: 6 as defined in the specification and which exhibits at least one property in common with vascular endothelial growth factor is claimed. A nucleic acid molecule encoding the amino acid sequence having at least 70% similarity to the amino sequence SEQ. ID NO: 6 as defined in the specification and which exhibits at least one property in common with vascular endothelial growth factor is also claimed. A pharmaceutical composition containing the above defined peptide useful for inducing astroglial proliferation and promoting neuronal survival and/or proliferation is claimed.
Patent NZ-331020-A (NZ)
Title: Limit switch system for hydraulic elevators, limit switches mounted on car
Inventor: KOEPPE ROBERT J
IPC: B66B1/50
Filed: 1998-07-17
Abstract: n elevator car 1 has at least one upper switch 5 and at least one lower switch 8 mounted on the car, and which are actuated by fixed cams 3, 4.  The elevator controller includes an interlock circuit which generates slowdown and/or limit signals depending on direction signals from the controller when the switches are actuated.  This arrangement allows as few as two switches to act as limit or slowdown switches according to the direction of travel of the elevator.
Patent NZ-332322-A (NZ)
Title: DNA sequence encoding a high molecular weight protein of non-typeable Haemophilus strain
Inventor: BARENKAMP STEPHEN J
IPC: A61K38/00
Filed: 1997-04-01
Abstract: An isolated and purified nucleic acid molecule encoding high molecular weight protein (HMW) HMW3 or HMW4 of non-typeable Haemophilus is claimed having: a)	the DNA sequence SEQ ID No. 7 as shown in the specification and encoding protein HMW3 having the derived amino acid sequence of SEQ ID No 10 as shown in the specification or b)	the DNA sequence SEQ ID No. 9 as shown in the specification and encoding protein HMW3 having the derived amino acid sequence of SEQ ID No 10 as shown in the specification A vector for the transformation of a host containing the above defined nucleic acid molecule is claimed.